Skip to main content
. 2020 Jul 28;10(3):843–853. doi: 10.3233/JPD-201969

Table 6.

Analysis of PD gait parameters according to the “ON/OFF” medication state during the gait assessment

Wearable devices
All “ON” State Medication Healthy controls
Gait velocity 1.01±0.26 (32) 1.06±0.20 (29) 1.19±0.31 (17)
Cadence 106.68±20.57 (11) 112.33±8.89 (10) 113.34±7.55 (6)
Stride Length 1.14±0.28 (18) 1.15±0.26 (15) 1.37±0,08 (8)
Stride Time 1.18±0.17 (13) 1.18±0.18 (12) 1.09±0.07 (9)
Stride Time Var 3.84±2.94 (12) 4.01±3.02 (11) 2.18±0.59 (9)
Double support phase 29.03±5.00 (8) 29.22±5.37 (7) 23.40±5.83 (6)
Non-wearable devices
All “ON” State Medication Healthy controls
Gait velocity 1.00±0.25 (19) 1.01±0.25 (18) 1.15±0.32 (5)
Cadence 104.04±9.57 (15) 105.75±7.15 (14) NA
Stride Length 0.77±0.40 (19) 0.77±0.43 (17) 1,20±0.28 (4)
Step Length 0.54±0.13 (17) 0.55±0.13 (16) 0.64±0.06 (6)